Tag Archives: SciClone

SciClone Pharmaceuticals: Selling Specialty Drugs in China

By Ben Comer | Published: October 1, 2012
US-based SciClone Pharmaceuticals has built its business around selling specialty drugs in China. Companies like Sanofi and Pfizer, despite their own in-country resources, have partnered with SciClone and are achieving better returns, according to SciClone CEO Friedhelm Blobel.
Posted in Biotech, Emerging Markets, Global, IP, Legal, Manufacturing, People, Regulatory, Sales, Strategy, compliance, healthcare, pricing | Also tagged , | 1 Comment